GAITHERSBURG, Md., May 18, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma"...
GAITHERSBURG, Md., May 16, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma"...
FY2023 Revenues Increased by Approximately 30% Year Over Year GAITHERSBURG, Md., April 18, 2023 /P...
* The trial met its primary endpoint of superior immunogenicity of PIKA COVID-19 Vaccine vs inact...
YS Biopharma Ordinary Shares and Warrants to Trade on the Nasdaq Under Tickers "YS" and "YSBPW" ...
* Business Combination to deliver approximately $36 million of gross proceeds * YS Biopharma exp...
* Extraordinary general meeting of Summit Healthcare Acquisition Corp.'s shareholders to be held ...
* Extraordinary general meeting of Summit Healthcare Acquisition Corp.'s shareholders to be held ...
GAITHERSBURG, Maryland, Nov. 16, 2022 /PRNewswire/ -- YS Biopharma Co., Ltd. ("YS Biopharma" or th...
NEW YORK, Nov. 10, 2022 /PRNewswire/ -- YS Biopharma Co., Ltd. ("YS Biopharma" or the "Company"), a...
* Transaction values YS Biopharma at pre-money equity value of $834 million * Certain investors ...
BEIJING, Sept. 8, 2022 /PRNewswire/ -- YishengBio Co., Ltd., ("YishengBio"), a biopharmaceutical co...